Perrigo agrees to acquire Elan
Perrigo Co. is acquiring Elan Corp., an Irish pharmaceutical firm, for $8.6 billion in a transaction that should give the manufacturer of over-the-counter drugs a low tax base for international expansion.
Perrigo Co. is acquiring Elan Corp., an Irish pharmaceutical firm, for $8.6 billion in a transaction that should give the manufacturer of over-the-counter drugs a low tax base for international expansion.
Endo Health Solutions Inc. has appointed Don DeGolyer as chief operating officer of pharmaceuticals, which includes the company’s Endo Pharmaceuticals and Qualitest business units. Endo said Monday that DeGolyer is slated to start as COO on Aug. 1.
Lannett Co. has signed an agreement with Symplmed Inc. to be the exclusive U.S. distributor of an authorized generic version of Aceon, a hypertension medication. Lannett said Friday that the authorized generic of Aceon (perindopril erbumine tablets) will come in dosages of 2 mg, 4 mg and 8 mg.
Mission Pharmacal Co. has ramped up retail distribution for Dr. Smith’s Diaper Rash Ointment, which it acquired in 2009. The company said Tuesday that Dr. Smith’s Diaper Rash Ointment is now available in all Walgreens drug stores and on Walgreens.com, as well as in Kroger Co. supermarkets.
Richard Lenny has been named chairman of the board at Information Resources Inc. (IRI). The consumer packaged goods (CPG), health and retail market research firm said Tuesday that Lenny succeeds Lawrence Benjamin, who will remain a member of the board and a senior adviser.
Mark Hill Salon Professional products, created by internationally acclaimed hairstylist Mark Hill, is launching nationwide at Walgreens and Duane Reade drug stores this month. The companies said Monday that the U.S.
Les Hamilton has been appointed executive vice president of Hyland’s Inc. and vice president of sales for parent company Standard Homeopathic Co.
Taro Pharmaceutical Industries Ltd. has announced senior leadership changes, including the appointment of a new chairman and a new chief executive officer. The company said Thursday that Dilip Shanghvi has been named chairman of the board and that, effective Aug.
Prostate health formula UrinoZinc has added to its product line available at Walmart. Vitanergy Inc., maker of the dietary supplement for men, said Wednesday that UrinoZinc Plus with Beta-Sitosterol is now available at almost all Walmart stores, which also carry UrinoZinc Prostate Formula.
The salon-quality Hot Legs hair removal system from Australia has launched in the United States at Walgreens drug stores nationwide and Duane Reade stores in metropolitan New York.
Mylan Inc. has launched norethindrone tablets 0.35 mg, a birth control pill. The company reported Tuesday that its partner, Famy Care Ltd., received final approval from the Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for the product. product Mylan Inc.
Healthrageous Inc. and Boehringer Ingelheim have launched the SMART Study along with United BioSource Corp. to assess a digital self-management solution to improve the health status of people with type 2 diabetes.
AquaBall Naturally Flavored Water from True Drinks Inc. is now available at Walgreens drug stores across the country. True Drinks said Tuesday that the retail distribution at Walgreens comes as it launches a national initiative to support healthy hydration in summer programs.
Actavis Inc. has been cleared to market lamotrigine orally disintegrating tablets, an anti-epileptic medication. The company said Monday that it plans to launch the product, a generic equivalent to GlaxoSmithKline’s Lamictal ODT, immediately.
Direct Digital LLC has landed retail distribution for its Instaflex Joint Support dietary supplement at Duane Reade. The company said Friday that Instaflex is now being carried at Duane Reade drug stores throughout the metropolitan New York area.
Mylan Inc. has released fenofibric acid delayed-release capsules, a medication for treating high levels of cholesterol and triglycerides. The company said Monday that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched the product in dosages of 45 mg and 135 mg.